Influence of Ocular Rigidity and Ocular Biomechanics on the Pathogenesis of Age-Related Presbyopia
This chapter discusses ocular rigidity and ocular biomechanical dysfunction as they relate to the age-related pathogenesis of presbyopia. The major factors associated with presbyopia as they relate to ocular rigidity and ocular biomechanical dysfunction are highlighted. Furthermore, specific reference is made to modifying the biomechanical properties and structural stiffness of the scleral outer coat utilizing laser scleral therapies. Recent literature has illuminated that the loss of accommodative ability in presbyopes has many contributing lenticular, as well as extralenticular and physiological factors which are affected by increasing age.
Explore More Articles
New-generation software further improves precision of laser scleral microporation
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Luca Gualdi, MD, speaks about the latest advances in laser scleral microporation. Laser scleral microporation (LSM, Ace Vision Group) is a treatment that restores accommodation in presbyopic patients by uncross-linking the scleral tissue that becomes stiff with age. It does so by performing arrays of micropores in …
read moreDynamic Range of Focus of the Eye: Understanding Biomechanics and Kinematics: Part 1
A PRIMARY FOCUS IN OPHthalmic health care has been on providing solutions to help our patients “see” more clearly and curtail the effects of uncurable age-related eye diseases, such as presbyopia, cataracts, glau-coma, and age-related macular degeneration (AMD). The eye contains more than 2 million working parts and is considered the second most complex organ …
read moreAce Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read more